The Deal Landscape At Mid-Year: Is Industry Following Through On Business Development Promises?

Pfizer/Biohaven Is Only $10bn-Plus M&A In First Half

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.